Exhalos Overview

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 2

Exhalos General Information

Description

Manufacturer of neonatal medical diagnostic devices intended to enable the detection of necrotizing enterocolitis in premature infants. The company offers a non-invasive, breath-based diagnostic tool that identifies metabolic biomarkers, enabling clinicians to perform timely interventions and improve outcomes in neonatal intensive care units.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • Arden Hills, MN
  • United States
Primary Industry
Diagnostic Equipment
Vertical(s)
Manufacturing, Life Sciences
Corporate Office
  • Arden Hills, MN
  • United States

Exhalos Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Exhalos Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 11-Jun-2024 Completed Startup
1. Grant 01-Jan-2024 Completed Startup
To view Exhalos’s complete valuation and funding history, request access »

Exhalos Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
The Consortium for Technology & Innovation in Pediatrics Accelerator/Incubator
UCSF-Stanford Pediatric Device Consortium Other
To view Exhalos’s complete investors history, request access »

Ready to get started?

Request a free trial

Exhalos FAQs

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process